EIKN
Eikon Therapeutics, Inc.
7.50$
+2.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| -0.44 | – | – | -1.10 | -0.77 | -1.66 | -1.20 | -4.73 | |
| 0.12 | – | – | 0.12 | 0.09 | 0.09 | 0.09 | 0.40 | |
| 0.06 | – | – | 0.07 | 0.07 | 0.05 | 0.08 | 0.27 | |
| 0.62 | – | – | 0.05 | 0.55 | -0.26 | 0.27 | 0.61 | |
| 0.73 | – | – | 0.05 | 0.00 | 0.00 | 0.00 | 0.06 | |
| – | – | – | 0.51 | 0.75 | -3.75 | 0.86 | -1.63 | |
| 0.00 | – | – | 0.00 | 0.02 | 6.45 | 0.00 | 6.48 | |
| -0.29 | – | – | -0.59 | 0.00 | 1.04 | -0.34 | 0.11 | |
| -1.17 | – | – | -1.15 | -0.77 | -1.66 | -1.20 | -4.79 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.